Literature DB >> 31040675

Sleep problems in children with autism spectrum disorder: clinical correlates and the impact of attention deficit hyperactivity disorder.

Serkan Gunes1, Ozalp Ekinci2, Aynur Feyzioglu3, Nuran Ekinci4, Merve Kalinli5.   

Abstract

PURPOSE: High prevalence of sleep problems has been reported in children with autism spectrum disorder (ASD). However, there is limited literature about the types and clinical correlates of sleep problems. This study aims to compare sleep disturbances between children with ASD and healthy children and investigate the relationship between sleep difficulties and clinical symptoms of ASD.
MATERIALS AND METHODS: The sample consisted of 112 children in ASD patient group and 112 healthy controls, with an age range of 2-18 years. The Children's Sleep Habits Questionnaire (CSHQ) was used for sleep problems; Turgay DSM-IV Disruptive Behavior Disorders Rating Scale parent form (T-DSM-IV-S) was used to assess hyperactivity/impulsivity and inattentiveness; Childhood Autism Rating Scale (CARS), Autism Behavior Checklist, and Aberrant Behavior Checklist were used to evaluate the severity of autistic symptoms and behav-ioral problems.
RESULTS: Total score, bedtime resistance, and sleep anxiety subscores of CSHQ were significantly higher in children with ASD than the control group. Among ASD children, intellectual capacity was not found to be associated with CSHQ scores. Bedtime resistance and night waking sub-scores of CSHQ were found to be positively correlated with CARS total score. Inattentiveness subscore of Parent T-DSM-IV-S was significantly higher in children with moderate-to-severe sleep problems.
CONCLUSION: Sleep difficulties in ASD patients may occur independently of intellectual disability. Bedtime resistance and night waking appear to be linked with ASD symptoms. Inattentiveness in ASD children may be associated with moderate-to-severe sleep problems.

Entities:  

Keywords:  ADHD; ASD; autism; sleep; sleep problems

Year:  2019        PMID: 31040675      PMCID: PMC6452798          DOI: 10.2147/NDT.S195738

Source DB:  PubMed          Journal:  Neuropsychiatr Dis Treat        ISSN: 1176-6328            Impact factor:   2.570


Introduction

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairments in three developmental areas: social interaction, communication, and restricted and repetitive behaviors.1 The epidemiological research shows about 1 per 68 children have ASD in the US, and males are four times more likely than females to receive the diagnosis.2 Although the underlying etiology of ASD is unknown, it is suggested that ASD is most likely caused by the interaction of genetic and environmental factors.3,4 Sleep is necessary for human life and has a crucial role in synaptic development and brain maturation. The relationship between sleep and brain functions is complicated.4 Poor sleep may have adverse effects on children’s attention, memory, learning, and behavior. Prior studies have found that sleep disorders are related with inattention, hyperactivity, aggression, and conduct problems in children.5 Insufficient sleep is reported to be associated with deficits in nonverbal intelligence and communication.6 Additionally, disrupted or restricted sleep may be a predictor of social skills deficits.3 Previous reports state that sleep problems are common in children with ASD. Sleep disorder is one of the most frequent comorbid conditions for ASD children. Sleep disturbances are found in 70%–75% of the children with ASD and 45%–50% of healthy children.5 It is also known that sleep disorders among ASD children are more chronic in nature than in typically developing children.8 Sleep problems in ASD may occur as a result of multiple interactions between biological, psychological, medical, social, and environmental factors.3,9 Irregularity in melatonin levels and secretion patterns and abnormalities in clock-related genes have been suggested as potential intrinsic factors. For example, arousal dysregulations due to genetic alterations may be related with hypersensitivity to environmental stimuli and sleep problems in children with ASD.9 Sleep disorders in ASD may cause secondary behavioral problems, such as hyperactivity, mood variability, irritability, and worsening in autistic symptoms.6,9 Although many studies on sleep problems and ASD have been published, the types of sleep difficulties and exact correlations have not yet been revealed.3,7 The clarification of sleep problems in ASD is important for several reasons. The diagnosis and effective management of sleep problems may lead to an improvement in behavioral problems. The improvement in behavioral problems, such as hyperactivity, inattentiveness, and aggression, may, in turn, increase the compliance of children to educational interventions. In this study, we aim to compare sleep problems in children with ASD and healthy individuals and investigate the association between sleep problems and clinical symptoms of ASD. The intellectual level, ASD symptom severity, and attention deficit hyperactivity disorder (ADHD) were specifically examined as associated factors of sleep problems in ASD.

Materials and methods

Participants and procedure

This study was a cross-sectional, cohort survey of children and adolescents with ASD who were recruited from the Child and Adolescent Psychiatry Department of Hatay State Hospital between January and August 2018. The nature and purpose of the study were explained to all parents and written informed consent was obtained from the parents of all children. This study was conducted in accordance with the Declaration of Helsinki and the study protocol was approved by the Ethics Committee of Adana City Hospital in Adana in Turkey. The inclusion criteria for the patient group were as follows: 1) ASD diagnosis according to DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition);1 2) an age range of 2–18 years; 3) not having a chronic physical illness other than ASD; and 4) not using any medications for at least 6 months. ASD diagnosis was made with developmental histories, clinical symptoms and observations, Childhood Autism Rating Scale (CARS), and checklists. For the control group, the following inclusion criteria were used as follows: 1) no psychiatric disorder diagnosis according to DSM-5 (not meeting the diagnostic criteria of any psychiatric disorder according to DSM-5); 2) an age range of 2–18 years; 3) not having a chronic physical or mental illness; 4) not using any medications for at least 6 months; 5) for preschoolers, normal developmental history and normal Denver II Test; and 6) for school-aged children, normal intelligence based on either a Wechsler Intelligence Scale for Children-Revised (WISC-R)10 full-scale IQ score above 80 or the average/above academic functioning documented with the last year’s final school grades. Intellectual capacities of children in both patient and control groups were examined. A child development specialist performed Denver II Test on children under 6 years. An experienced psychologist performed WISC-R full-scale on children over 6 years. Children who could not adapt to Denver II Test and WISC-R full-scale were evaluated with developmental histories, clinical symptoms and observations, and the average academic functioning documented with the last year’s final school grades. In the patient group, children with normal intellectual capacity and borderline intellectual disability were accepted as normal, and children with mild, moderate, and severe intellectual disability were accepted as intellectually disabled. Initially, 126 children with DSM-5 ASD diagnosis were recruited. However, 14 children were excluded for the following reasons: three parents of children with ASD did not want to participate in the study, five children had a chronic medical illness, and six children were using a medication. In total, 112 children and adolescents with ASD and 112 healthy controls (an equal number with patients) completed the study requirements and were included to the study.

Measures

The Children’s Sleep Habits Questionnaire (CSHQ) The CSHQ is a retrospective, 45-item parent questionnaire that has been used in previous studies to examine sleep problems in children.11 The CSHQ includes items: sleep onset delay, sleep duration, sleep anxiety, night waking, sleep-disordered breathing, parasomnias, and morning waking/daytime sleepiness. Items are rated on a three-point scale: “usually” if the sleep behavior occurred five to seven times/week; “sometimes” for two to four times/week; and “rarely” for zero to one time/week.12 A total score >41 is suggested to be the cutoff for identifying sleep problems.9 Fiş et al administered the Turkish translation of the scale.13 In the present study, based on the approach of a previous study,14 CSHQ scores of 56 and above were defined as moderate-to-severe sleep problems.

Turgay DSM-IV Disruptive Behavior Disorders Rating Scale parent form

Turgay DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition)15 Disruptive Behavior Disorders Rating Scale parent and teacher forms (T-DSM-IV-S) were designed by Turgay16 and translated by Ercan et al17 into Turkish. The T-DSM-IV-S is based on DSM-IV diagnostic criteria and examines hyperactivity/impulsivity, inattention, opposition-defiance, and conduct disorder. Symptoms are scored on a four-point Likert scale (0= not at all, 1= just a little, 2= quite a bit, and 3= very much).12 In our study, hyperactivity/impulsivity, inattention, and ADHD total scores of the scale were used. T-DSM-IV-S has been reported as a reliable and valid scale for ADHD symptoms.16,17 T-DSM-IV-S was administered to the patient group in the study.

CARS

The CARS consists of 15 items, and all the items contribute equally to one total score. Each item is rated by half scoring between 1 and 4.18 The scale is rated by clinicians according to the information obtained from child observations and family interviews. Items of the scale are as follows: interpersonal relationships, imitation, emotional response, body use, object use, adaptation to change, visual response, listening response, taste and smell responses, use of touch, fear/nervousness, verbal communication, nonverbal communication, activity level, level of intellectual response, and general impressions. A score of 15–29 points represent the child does not have autism, 30–36.5 points represent mild-to-moderate autism, and 37–60 points represent severe autism. For the Turkish version of the scale, item analysis shows that all items (except item 14) differentiate children with mild-to-severe autism.19 According to CARS total score, children with ASD were divided into two groups: children with mild-to-moderate ASD and children with severe ASD.

Autism Behavior Checklist (AuBC)

The AuBC is primarily used in determining the frequency and severity of autistic symptoms.20 It can be rated by both caregivers and teachers of the children. The checklist includes 57 questions divided into five categories as follows: sensory, relating (social skills), body and object use, language, and social and self-help. The validity and the reliability of AuBC were satisfying for the Turkish sample.21

Aberrant Behavior Checklist (AbBC)

The AbBC is useful for evaluating behavioral problems in children.22 It may be rated by caregivers or teachers of the children. It consists of 58 items, and each item is rated on a four-point scale ranging from 0 (not a problem) to 3 (the problem is severe). The scoring of the items indicates five subscales: irritability, lethargy-social withdrawal, stereotypic behavior, hyperactivity, and inappropriate speech. The Turkish translation and adaptation of the checklist were conducted by Sucuoglu23 and Karabekiroglu and Aman.24

Statistical analysis

The collected data were analyzed by using the SPSS version 21.0. Demographic variables were presented by using descriptive statistics. Categorical variables were compared by using chi-squared test. Kolmogorov–Smirnov and Shapiro–Wilk tests were used to verify normality in all continuous variables. All data were with a Gaussian distribution. Normally distributed parametric variables were compared between groups by using independent samples t-test. Pearson’s correlation analysis was used to examine the correlations. The P-value <0.05 was accepted to be statistically significant.

Results

Demographic and clinical characteristics

The sample consisted of 112 children and adolescent in ASD patient group and 112 healthy individuals, with an age range of 2–18 years (M=8.54, SD=3.20). Mean age of the patient group was 8.06 (SD=3.22) years, and 72.3% (N=81) were males. Control group had a mean age of 9.01 (SD=3.12) years, and 66.1% (N=74) were males. There were no statistically significant differences in age and gender (P>0.05). About 46.4% (N=52) of the patients were having mild-to-moderate ASD, and 53.6% (N=60) were having severe ASD. About 41.1% (N=46) of the patient group had a normal intellectual capacity, and 58.9% (N=66) had an intellectual disability (Table 1).
Table 1

Demographic variables and clinical characteristics of the sample

ASD patients, N=112Controls, N=112
Age (mean, SD)In years8.06 (3.22)9.01 (3.12)
Gender (N, %)Male81 (72.3)74 (66.1)
Intellectual capacity (N, %)NormalIntellectual disability46 (41.1)66 (58.9)100 (100)
ASD severity (N, %)Mild-to-moderateSevere52 (46.4)60 (53.6)

Abbreviation: ASD, autism spectrum disorder.

Comparison of CSHQ scores among study groups

Table 2 shows the comparison of CSHQ scores between the patient and control groups. Total score, t(222)=2.23, P=0.026; bedtime resistance, t(222)=2.03, P=0.043; and sleep anxiety, t(222)=2.48, P=0.014 subscores were significantly higher in the patient group when compared to the control group. Night waking, t(222)=0.95, P=0.343; parasomnias, t(222)=1.36, P=0.173; and sleep-disordered breathing, t(222)=0.54, P=0.589, subscores were higher in the patient group, but these findings were not statistically significant.
Table 2

The comparison of CSHQ scores between the patient and control groups

CSHQASD patients, N=112mean (SD)Controls, N=112mean (SD)Cohen’s dP-value
Total score53.01 (7.59)50.63 (7.44)0.3160.026
Bedtime resistance10.98 (2.26)10.34 (2.17)0.2880.043
Sleep onset delay6.15 (1.32)6.27 (1.38)−0.0880.532
Sleep anxiety6.30 (2.15)5.60 (1.80)0.3530.014
Night waking4.08 (1.46)3.90 (1.19)0.1350.343
Daytime sleepiness13.35 (3.55)13.37 (3.17)−0.0050.967
Parasomnias9.15 (2.85)8.63 (2.50)0.1930.173
Sleep-disordered breathing3.55 (1.20)3.46 (1.14)0.0760.589

Abbreviations: ASD, autism spectrum disorder; CSHQ, Children’s Sleep Habits Questionnaire.

Relationship between clinical symptoms and sleep problems

When all of the CSHQ scores were compared according to intellectual capacity (Table 3) and ASD severity (Table 4) in the patient group, no significant difference was found (total score t(110)=0.78, P=0.435 and t(110)=1.74, P=0.084, respectively).
Table 3

The comparison of CSHQ scores between ASD patients with normal intellectual capacity and intellectual disability

CSHQNormal intellectualcapacity, N=46 mean (SD)Intellectual disability,N=66 mean (SD)Cohen’s dP-value
Total score52.30 (8.28)53.51 (7.07)0.1570.435
Bedtime resistance10.61 (2.20)11.24 (2.29)0.2800.177
Sleep onset delay6.40 (1.25)5.96 (1.36)−0.3360.103
Sleep anxiety6.30 (2.18)6.29 (2.16)−0.0040.970
Night waking3.76 (1.20)4.31 (1.60)0.3880.065
Daytime sleepiness13.35 (3.46)13.34 (3.64)−0.0020.986
Parasomnias8.50 (2.66)9.62 (2.92)0.4000.052
Sleep-disordered breathing3.64 (1.47)3.48 (0.95)−0.1290.513

Abbreviations: ASD, autism spectrum disorder; CSHQ, Children’s Sleep Habits Questionnaire.

Table 4

The comparison of CSHQ scores between patients with mild-to-moderate ASD and severe ASD

CSHQMild-to-moderateASD, N=52, mean (SD)Severe ASD,N=60, mean (SD)Cohen’s dP-value
Total score51.70 (7.91)54.32 (7.09)0.3480.084
Bedtime resistance10.60 (2.23)11.36 (2.26)0.3380.094
Sleep onset delay6.30 (1.18)6.00 (1.45)−0.2260.261
Sleep anxiety6.06 (2.10)6.54 (2.20)0.2230.268
Night waking3.80 (1.22)4.36 (1.63)0.3880.056
Daytime sleepiness13.14 (3.39)13.56 (3.72)0.1180.557
Parasomnias8.62 (2.78)9.68 (2.86)0.3750.063
Sleep-disordered breathing3.62 (1.38)3.48 (0.99)−0.1160.563

Abbreviations: ASD, autism spectrum disorder; CSHQ, Children’s Sleep Habits Questionnaire.

The correlations between CSHQ scores and CARS, AuBC, and AbBC total scores are shown in Table 5. As seen in the table, bedtime resistance, r(112)=0.19, P=0.048, and night waking, r(112)=0.20, P=0.045, were found to be positively correlated with CARS total score. There was no significant correlation between CSHQ scores and AuBC and AbBC total scores. We also investigated the correlations between CSHQ scores and age and intellectual capacity. None of these correlations were significant (Figures 1 and 2).
Table 5

The correlations between CSHQ scores and CARS, AuBC, and AbBC total scores

CSHQCARSAuBCAbBC
rP-valuerP-valuerP-value
Total score0.1070.2910.0690.503−0.0310.763
Bedtime resistance0.1980.0480.0680.5100.1500.143
Sleep onset delay−0.1480.140−0.0860.401−0.1470.152
Sleep anxiety0.0790.4350.1110.2780.0450.662
Night waking0.2010.0450.1600.1180.0850.406
Daytime sleepiness−0.0180.8570.0600.561−0.0090.928
Parasomnias0.1830.0680.1610.1140.0800.437
Sleep-disordered breathing−0.0970.335−0.1310.202−0.1170.253

Abbreviations: CSHQ, Children’s Sleep Habits Questionnaire; CARS, Childhood Autism Rating Scale; AuBC, Autism Behavior Checklist; AbBC, Aberrant Behavior Checklist.

Figure 1

The correlation between bedtime resistance subscore and CARS total score in ASD patients. The Pearson product-moment correlation coefficient between bedtime resistance subscore and CARS total score was calculated in 112 ASD patients (r=0.19, P=0.048).

Abbreviations: ASD, autism spectrum disorder; CARS, Childhood Autism Rating Scale.

Figure 2

The correlation between night waking subscore and CARS total score in ASD patients. The Pearson product-moment correlation coefficient between night waking subscore and CARS total score was calculated in 112 ASD patients (r=0.20, P=0.045).

Abbreviations: ASD, autism spectrum disorder; CARS, Childhood Autism Rating Scale.

Table 6 shows the comparison of clinical symptoms of ASD between patients with CSHQ <56 and CSHQ >56. As seen in the table, inattentiveness, t(110)=−1.98, P=0.045, subscore of Parent T-DSM-IV-S was significantly higher in the CSHQ >56 group. No significant difference was found between the groups for total score, t(110)=−1.12, P=0.263, and hyperactivity, t(110)=−0.81, P=0.415, subscore. CARS, AuBC, and AbBC total scores and subscores were compared between the groups, but there was no significant difference (total score t(110)=−0.02, P=0.978; t(110)=0.01, P=0.985; and t(110)=0.58, P=0.561, respectively).
Table 6

The comparison of clinical symptoms between ASD patients with CSHQ <56 and CSHQ >56

CSHQ <56, N=58 mean (SD)CSHQ >56, N=54 mean (SD)Cohen’s dP-value
Parent T-DSM-IV-S Total31.03 (18.39)35.62 (21.40)0.2300.263
 Inattentiveness11.89 (6.89)14.82 (7.33)0.4110.045
 Hyperactivity12.04 (6.69)13.25 (7.70)0.1670.415
CARS total37.66 (6.55)37.70 (7.16)0.0050.978
AuBC total55.45 (21.17)55.54 (23.09)0.0040.985
AbBC total58.45 (18.23)60.70 (18.24)0.1230.561

Abbreviations: ASD, autism spectrum disorder; CSHQ, Children’s Sleep Habits Questionnaire; T-DSM-IV-S, Turgay DSM-IV Disruptive Behavior Disorders Rating Scale; CARS, Childhood Autism Rating Scale; AuBC, Autism Behavior Checklist; AbBC, Aberrant Behavior Checklist.

When the patients with CSHQ <56 and CSHQ >56 were compared according to intellectual capacity and ASD severity, no significant difference was found (X2(1, N=112) =0.30, P=0.581 and X2(1, N=112) =0.39, P=0.529, respectively).

Discussion

Previous studies have suggested that difficulties with sleep onset and maintenance and with reduced sleep duration are the most common sleep disorders in children with ASD.8,9,25 Other sleep disturbances in ASD include parasomnias like sleepwalking, night terrors, and sleep-related movement disorders as well as bedtime resistance.8,25 Our findings based on parent reports are generally consistent with the literature, regarding both the higher frequency of sleep problems in ASD and the types of sleep problems. Sleep patterns in children with intellectual disabilities have been investigated in a number of studies.26–28 In these studies, children with intellectual disabilities were more likely to have high sleep problems than healthy individuals, and more severe levels of intellectual disability were associated with more sleep difficulties.26–28 However, in the ASD group alone, there are only a few reports about the relationship between cognitive development and sleep problems.6,26 We found no significant differences between ASD patients with normal intellectual capacity and intellectual disability regarding sleep disturbances. This result was consistent with previous reports indicating that sleep disorders can appear at all IQ levels.6,26 In light of these findings, it can be speculated that sleep problems in ASD can occur independently of intellectual disability. The results of previous studies about the association between sleep problems and ASD severity were inconsistent.7,29,30 Adams et al emphasized a strong correlation between sleep difficulties and autism symptom severity.29 They suggested a bidirectional relationship that ASD severity was a strong predictor of sleep disturbances and a disordered sleep aggravated daytime symptoms. Mayes and Calhoun found a significant correlation between sleep problems and parent and clinician ratings of autism severity, but not teacher ratings.30 In another study, Mutluer et al reported that neither subtype nor ASD severity had a direct relationship with sleep disturbances.7 However, in that study, the subgroups were small and not equal in size. Similar to Mutluer’s study, our study results showed no significant relationship between sleep problems and ASD severity. The occurrence of different outcomes in studies may depend on other factors affecting sleep quality and autistic symptom severity, such as medications or family factors. The possible associations between sleep disorders and behavioral problems in children with ASD have been the subject of many studies. Most of these studies showed a relationship between sleep disturbances and behavioral problems.5–7,9,14,31 In our study, we found bedtime resistance and night waking scores of CSHQ were positively correlated with CARS total score. With this result, it can be considered that bedtime resistance and night waking may have a significant impact on autistic symptoms and they may be important targets for the treatment regimen. Interestingly, there was no significant correlation between CSHQ scores and AuBC and AbBC total scores. Differences in scale scores may partly reflect rater differences. CARS is rated by clinicians while AuBC and AbBC are rated by parents. Discrepancies between clinician- and parent-rated scales are frequently observed in child psychiatry clinical practice. Generally, clinician-rated scales may be considered as more reliable in ASD, since parental reporting bias is common. The lack of a significant correlation with AuBC and AbBC may be due to bias or halo effect in our study. Poor sleep may be related to a variety of neuropsychological conditions in children and adolescents. A study conducted by Brand et al showed that poor sleep might lead to worsened emotional competence in adolescents.32 A recent study indicated an opposite effect of rapid eye movement sleep on neurobehavioral functioning and procedural intelligence, depending on presence or absence of a spectrum of child psychiatric disorders.33 In another study, Schneider et al suggested that although sleep problems were common in young children with ADHD, inattention and executive dysfunction appeared to be attributable to symptoms of ADHD, rather than to sleep disturbance.34 In a review article evaluating the relationship between sleep disorders and ADHD, it was concluded that sleep problems could negatively affect the symptoms of inattentiveness, hyperactivity/impulsivity, and neurobehavioral functions.35 Symptoms of ADHD have also been shown to be associated with sleep problems in children with ASD.8,30,36–38 Mayes and Calhoun reported hyperactivity, mood variability, and aggression were strong predictors of sleep difficulties.30 In another study, Goldman et al suggested that poor sleepers had more inattentiveness, hyperactivity, and restricted/repetitive behaviors than good sleepers.38 In the present study, we found inattentiveness subscore of Parent T-DSM-IV-S was significantly higher in the CSHQ >56 group. This association between inattentiveness and poor sleep quality in ASD may be best conceptualized as a bidirectional relationship. It may be suggested that sleep disturbances may exacerbate daytime inattentiveness, or conversely, inattention symptoms may be a predictor of an irregular sleep–wake cycle.

Limitations

The current study has several limitations. The cross-sectional nature of the study indicates a limitation. Therefore, it is necessary to interpret the results carefully. Second limitation is that the age range is relatively large (2–18 years). The types and severity of sleep disorders may vary in different age groups. Another major limitation is the reliance on parent reports. Parental problems may influence their perception of child condition. For example, distressed parents may view their children’s sleep and attention more negatively. On the other hand, CSHQ was used in many studies of children and adolescents with ASD, but it was developed for use among children, not adolescents.5 Polysomnography and actigraphy are objective measures and can be used to accurately identify sleep problems in children and adolescents.5,7 Additionally, the exclusion of patients on medication treatment may also be considered as a limitation. Some of the children with ASD who were excluded might have sleep problems, since sleep problems are among the most common indications for medication use in ASD.

Conclusion

This study compared sleep problems between children with ASD and typically developing children and examined associated factors of sleep problems in ASD from a different point of view. The symptom dimensions of ADHD, intellectual level, and ASD symptom severity were all investigated as possible clinical correlates of sleep problems. Therefore, our findings may provide a new insight into the relationship between sleep problems and ASD. The study results show that children with ASD are at high risk for sleep disturbances. It is necessary to evaluate sleep and related problems in this patient group. Sleep disorders may negatively affect the autistic symptoms and inattentiveness in ASD children. The successful intervention for these sleep problems may prevent functional impairments and improve the clinical symptoms and quality of life of both patients and parents.
  23 in total

1.  Defining the sleep phenotype in children with autism.

Authors:  Suzanne E Goldman; Kyla Surdyka; Ramon Cuevas; Karen Adkins; Lily Wang; Beth A Malow
Journal:  Dev Neuropsychol       Date:  2009       Impact factor: 2.253

2.  The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children.

Authors:  J A Owens; A Spirito; M McGuinn
Journal:  Sleep       Date:  2000-12-15       Impact factor: 5.849

3.  Sleep disturbance and neuropsychological function in young children with ADHD.

Authors:  Heather E Schneider; Janet C Lam; E Mark Mahone
Journal:  Child Neuropsychol       Date:  2015-03-13       Impact factor: 2.500

Review 4.  Sleep problems in autism spectrum disorders: prevalence, nature, & possible biopsychosocial aetiologies.

Authors:  Amanda L Richdale; Kimberly A Schreck
Journal:  Sleep Med Rev       Date:  2009-04-24       Impact factor: 11.609

5.  Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study.

Authors:  Paula Krakowiak; Beth Goodlin-Jones; Irva Hertz-Picciotto; Lisa A Croen; Robin L Hansen
Journal:  J Sleep Res       Date:  2008-06       Impact factor: 3.981

6.  Sleep problems and daytime problem behaviours in children with intellectual disability.

Authors:  R Didden; H Korzilius; B van Aperlo; C van Overloop; M de Vries
Journal:  J Intellect Disabil Res       Date:  2002-10

7.  Validity of the aberrant behavior checklist in a clinical sample of toddlers.

Authors:  Koray Karabekiroglu; Michael G Aman
Journal:  Child Psychiatry Hum Dev       Date:  2008-07-04

Review 8.  Sleep problems and their effect in ADHD.

Authors:  Roumen Kirov; Serge Brand
Journal:  Expert Rev Neurother       Date:  2014-02-04       Impact factor: 4.618

9.  The relationship between sleep problems and daytime behavior in children of different ages with autism spectrum disorders.

Authors:  Darryn M Sikora; Kyle Johnson; Traci Clemons; Terry Katz
Journal:  Pediatrics       Date:  2012-11       Impact factor: 7.124

Review 10.  The relationship between sleep and behavior in autism spectrum disorder (ASD): a review.

Authors:  Simonne Cohen; Russell Conduit; Steven W Lockley; Shantha Mw Rajaratnam; Kim M Cornish
Journal:  J Neurodev Disord       Date:  2014-12-11       Impact factor: 4.025

View more
  4 in total

1.  Parent-reported sleep problems in children and adolescents with sickle cell disease: relationship to health-related quality of life.

Authors:  Serkan Gunes; Rahime Aldemir; Adem Gunes; Ozalp Ekinci
Journal:  Arch Med Sci       Date:  2021-01-26       Impact factor: 3.707

2.  Effects of Sleep Disturbances on Behavioral Problems in Preschool Children With Autism Spectrum Disorder.

Authors:  Ying Wang; Jingjing Lin; Ying Zeng; Yanan Liu; Yamin Li; Kun Xia; Jingping Zhao; Yidong Shen; Jianjun Ou
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

Review 3.  Examining the Relationship Between Sleep Quality, Social Functioning, and Behavior Problems in Children with Autism Spectrum Disorder: A Systematic Review.

Authors:  Sally Whelan; Arlene Mannion; Azeem Madden; Fine Berger; Rachel Costello; Saeid Ghadiri; Geraldine Leader
Journal:  Nat Sci Sleep       Date:  2022-04-14

4.  Effect of Daily Physical Activity on Sleep Characteristics in Children with Autism Spectrum Disorder.

Authors:  Thai Duy Nguyen; Michel Guinot; Véronique-Aurélie Bricout
Journal:  Sports (Basel)       Date:  2021-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.